Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-31

Clinical Trial Update: Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Adebelimab in combination with irinotecan liposome, oxaliplatin, fluorouracil, and calcium folinate as first-line therapy for pancrea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adebelimab (adebelimab)
  • Calcium folinate (calcium folinate)
  • FLUOROURACIL (Fluorouracil)
  • Irinotecan liposomal injection (irinotecan liposome injection)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Jiang Long | Conditions: Pancreatic Cancer Metastatic to Liver | Phase 2 | Status: RECRUITING